Insmed Incorporated
INSM
$72.65
$2.453.49%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -913.77M | -864.29M | -802.69M | -746.89M | -749.57M |
Total Depreciation and Amortization | 8.88M | 8.87M | 8.91M | 8.78M | 8.44M |
Total Amortization of Deferred Charges | 11.73M | 11.74M | 12.09M | 12.30M | 12.17M |
Total Other Non-Cash Items | 212.46M | 248.58M | 239.42M | 225.44M | 231.93M |
Change in Net Operating Assets | -3.18M | -23.63M | -31.87M | -73.61M | -39.22M |
Cash from Operations | -683.88M | -618.72M | -574.14M | -573.98M | -536.25M |
Capital Expenditure | -21.92M | -17.30M | -16.47M | -14.57M | -13.29M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -561.25M | -695.83M | 313.96M | 44.68M | -210.32M |
Cash from Investing | -583.18M | -713.13M | 297.49M | 30.12M | -223.60M |
Total Debt Issued | 150.00M | -- | -- | -- | -- |
Total Debt Repaid | -2.61M | -758.00K | -1.19M | -1.52M | -1.22M |
Issuance of Common Stock | 1.20B | 1.31B | 910.22M | 173.79M | 170.87M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -3.74M | 0.00 | 0.00 | -409.00K | -1.22M |
Cash from Financing | 1.34B | 1.30B | 909.03M | 171.86M | 168.44M |
Foreign Exchange rate Adjustments | -1.31M | 1.21M | 1.54M | -1.17M | -250.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 72.66M | -25.66M | 633.92M | -373.18M | -591.66M |